首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1547589

全球衣原體感染診斷市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Chlamydia Infection Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球披衣菌感染診斷市場需求將從 2023 年的 200 萬美元達到近 200 萬美元的市場規模，2024-2032 年研究期間複合年成長率為 9.02%。

沙眼衣原體 (CT) 是一種革蘭氏陰性細菌，可感染尿道、子宮頸和直腸的柱狀上皮，以及肺部和眼睛等非生殖器區域。衣原體感染或沙眼衣原體篩檢和診斷過程很簡單。檢測 CT 感染的程序包括尿液和分泌物檢測。它包括尿液測試或分泌物測試。在尿液測試中，在實驗室分析尿液樣本以檢查是否有感染。在分泌物檢測中，醫生會從子宮頸取出分泌物進行拭子進行披衣菌培養或抗原檢測。

市場動態

衣原體感染盛行率的上升以及隨之而來的預防和治療未來嚴重程度的診斷需求推動了全球衣原體感染診斷市場的發展。全球估計報告了 9000 萬沙眼衣原體病例。隨著性行為的改變、缺乏預防和教育，這一數字預計還會上升。性活動的開始時間和性伴侶的數量等幾個因素也會發揮作用。改進檢測方法並更快獲得結果預計將帶來新的市場機會。主要參與者正在投資開發和推出易於負擔和獲取的新產品。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球衣原體感染診斷市場的每個細分市場進行了包容性評估。衣原體感染診斷行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

衣原體感染診斷市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按測試類型

文化測試
核酸擴增檢驗（NAAT）
直接螢光抗體測試
血清學檢測
其他

按感染類型

生殖器衣原體感染
直腸披衣菌感染
眼衣原體感染

按最終用戶

診斷（醫院、專科診所、診斷中心）
治療學（醫院藥局、藥局、零售藥局、線上藥局）

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲衣原體感染診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。披衣菌感染診斷市場的主要參與者包括 Abbott、BD、Bio-Rad Laboratories Inc、Quidel Corporation、DiaSorin SpA、AstraZeneca、Teva Pharmaceutical Industries Limited。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：衣原體感染診斷公司的競爭格局

披衣菌感染診斷市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Abbott

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc

公司概況
公司收入
產品
最新動態

Quidel Corporation

公司概況
公司收入
產品
最新動態

DiaSorin SpA

公司概況
公司收入
產品
最新動態

AstraZeneca

公司概況
公司收入
產品
最新動態

Teva Pharmaceutical Industries Limited

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11214593

The global demand for Chlamydia Infection Diagnostics Market is presumed to reach the market size of nearly USD XX.X Million by 2032 from USD XX.X Million in 2023 with a CAGR of 9.02% under the study period 2024-2032.

Chlamydia trachomatis (CT) is a gram-negative bacterium that infects the columnar epithelium of the urethra, cervix, and rectum, as well as non-genital areas such as the lungs and eyes. Chlamydia infection or chlamydia trachomatis screening and diagnosis process are simple. The procedures to detect CT infections include urine and discharge test. It consists of a urine test or a discharge test. In a urine test, a sample of urine is analyzed in the laboratory to check infection presence. In a discharge test, the doctor takes a swab of the discharge from the cervix for culture or antigen testing for chlamydia.

MARKET DYNAMICS

The rising prevalence of chlamydia infection and the consequent need for diagnosis to prevent and treat future severity drives the global chlamydia infection diagnostics market. Globally, an estimated 90 million cases of Chlamydia trachomatis are reported. This figure is projected to rise with changes in sexual behaviour, lack of prevention, and education. Several factors like the beginning of the sexual activity and the number of sexual partners also play a role. Improving detection methods with faster results is expected to bring new market opportunities. Key players are investing in the development and introduction of new products which are easily affordable and accessible.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Chlamydia Infection Diagnostics. The growth and trends of Chlamydia Infection Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Chlamydia Infection Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Culture Test
Nucleic Acid Amplification Test (NAAT)
Direct Fluorescent Antibody Test
Serology Test
Other

By Type of Infections

Genital Chlamydia Infection
Rectal Chlamydia Infection
Ocular Chlamydia Infection

By End User

Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre)
Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Chlamydia Infection Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Chlamydia Infection Diagnostics market include Abbott, BD, Bio-Rad Laboratories Inc, Quidel Corporation, DiaSorin SpA, AstraZeneca, Teva Pharmaceutical Industries Limited. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CHLAMYDIA INFECTION DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By Type of Infections
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

5.1. Overview By Test Type
5.2. Historical and Forecast Data
5.3. Analysis By Test Type
5.4. Culture Test Historic and Forecast Sales By Regions
5.5. Nucleic Acid Amplification Test (NAAT) Historic and Forecast Sales By Regions
5.6. Direct Fluorescent Antibody Test Historic and Forecast Sales By Regions
5.7. Serology Test Historic and Forecast Sales By Regions
5.8. Other Historic and Forecast Sales By Regions

6. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY TYPE OF INFECTIONS

6.1. Overview By Type of Infections
6.2. Historical and Forecast Data
6.3. Analysis By Type of Infections
6.4. Genital Chlamydia Infection Historic and Forecast Sales By Regions
6.5. Rectal Chlamydia Infection Historic and Forecast Sales By Regions
6.6. Ocular Chlamydia Infection Historic and Forecast Sales By Regions

7. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data
7.3. Analysis By End User
7.4. Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre) Historic and Forecast Sales By Regions
7.5. Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies) Historic and Forecast Sales By Regions

8. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CHLAMYDIA INFECTION DIAGNOSTICS COMPANIES

9.1. Chlamydia Infection Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CHLAMYDIA INFECTION DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Abbott
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. BD
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Bio-Rad Laboratories Inc
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Quidel Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. DiaSorin SpA
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. AstraZeneca
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Teva Pharmaceutical Industries Limited
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Test Type (USD MN)
Culture Test Market Sales By Geography (USD MN)
Nucleic Acid Amplification Test (NAAT) Market Sales By Geography (USD MN)
Direct Fluorescent Antibody Test Market Sales By Geography (USD MN)
Serology Test Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Analysis By Type of Infections (USD MN)
Genital Chlamydia Infection Market Sales By Geography (USD MN)
Rectal Chlamydia Infection Market Sales By Geography (USD MN)
Ocular Chlamydia Infection Market Sales By Geography (USD MN)
Analysis By End User (USD MN)
Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre) Market Sales By Geography (USD MN)
Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies) Market Sales By Geography (USD MN)
Global Chlamydia Infection Diagnostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Chlamydia Infection Diagnostics Report
Market Research Process
Market Research Methodology
Global Chlamydia Infection Diagnostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Test Type
Market Attractiveness Analysis By Type of Infections
Market Attractiveness Analysis By End User
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Test Type (USD MN)
Culture Test Market Sales By Geography (USD MN)
Nucleic Acid Amplification Test (NAAT) Market Sales By Geography (USD MN)
Direct Fluorescent Antibody Test Market Sales By Geography (USD MN)
Serology Test Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Global Market Analysis By Type of Infections (USD MN)
Genital Chlamydia Infection Market Sales By Geography (USD MN)
Rectal Chlamydia Infection Market Sales By Geography (USD MN)
Ocular Chlamydia Infection Market Sales By Geography (USD MN)
Global Market Analysis By End User (USD MN)
Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre) Market Sales By Geography (USD MN)
Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies) Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis